36 results
8-K
SNSE
Sensei Biotherapeutics Inc
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
, 2023, Sensei Biotherapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC
DEFA14A
i2i q5qdryzzjg
23 May 23
Additional proxy soliciting materials
4:30pm
8-K
dt54re
23 May 23
Entry into a Material Definitive Agreement
4:26pm
DEF 14A
igxybs
28 Apr 22
Definitive proxy
4:13pm
S-3
EX-1.2
279pvjkez 0t01302b
15 Mar 22
Shelf registration
4:19pm
8-K
w543 7d9g5k
5 Apr 21
Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors
8:15am
10-K
3gggqibn8hn07c
30 Mar 21
Annual report
6:15am